SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently seeing intense community debate following its UAE regulatory milestone, with investors closely watching for official earnings release dates and potential global partnership announcements. While bulls highlight record product revenue growth and expanding international indications as long-term catalysts, critics are raising concerns about high cash burn rates and the lack of a clear timeline for the previously promised strategic news.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is surging following a blowout earnings report that shattered expectations with 93% revenue growth and significant guidance raises, driven by massive demand in both U.S. commercial and government sectors. The community is actively debating the stock's valuation as bulls celebrate the company's accelerating AI adoption and fundamental strength while bears remain skeptical of the high price-to-sales multiple.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing high volatility as the stock reacts to news of a potential U.S. ban on Chinese-made data center components, which investors view as a catalyst for hyperscalers to shift procurement toward Western suppliers. The community remains heavily divided between long-term bulls betting on AI infrastructure growth and short-term traders debating whether the stock's recent price action is fueled by solid fundamentals or speculative market manipulation.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is gaining momentum as investors track surging AI infrastructure demand and the potential impact of pending U.S. restrictions on Chinese data center components. The community is actively debating the company's long-term commercialization strategy, potential acquisition prospects, and recent board expansions while reacting to volatility driven by sector-wide rotation and options market activity.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digital is trending as investors react to bullish analyst upgrades and a broader sector rotation into AI infrastructure, with community sentiment fueled by confidence in the company's executed capacity delivery and the growing power demands of hyperscalers. While some discuss the transition from traditional mining to HPC, the focus remains on the company's ability to capitalize on the AI buildout while outperforming expectations in a competitive energy landscape.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as investors debate whether the stock is a deep-value turnaround opportunity or dead money, following a JP Morgan downgrade that cited persistent revenue headwinds in China and concerns over the company's long-term profitability. While the community is dividedwith some retail investors aggressively buying the dip in anticipation of a massive squeeze and others dismissing the stock as obsoletethe conversation is heavily focused on the companys ability to execute its turnaround strategy and regain cultural relevance.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is currently trending as investors weigh an impending earnings report against mixed sentiment regarding the company's AI-integrated Spectacles and ongoing ad market recovery. The community remains deeply divided, with bulls pointing to robust user engagement and improved monetization potential as a catalyst for a turnaround, while bears cite concerns over leadership, regulatory hurdles, and historical volatility surrounding the stock's performance after earnings.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh strong core operational growth and a raised revenue outlook against persistent investor frustration over the stock's long-term range-bound performance and leadership concerns. While many community members remain committed to the company's dividend potential and pipeline progress, others are actively debating whether an acquisition or significant management change is necessary to break the current cycle of stagnant price action.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is hovering near all-time highs as traders weigh a rally fueled by big tech earnings and cooling geopolitical tensions against ongoing skepticism regarding the sustainability of the current market structure. The community remains deeply divided, with bulls pointing to resilient momentum and AI-driven growth while vocal bears characterize the index's climb as a coordinated, liquidity-fueled move detached from economic reality.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending due to persistent geopolitical tension in the Middle East and ongoing uncertainty regarding the Strait of Hormuz, which continues to threaten global supply chains. Community members are actively debating the potential for further escalations and whether recent diplomatic signals are genuine or merely market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vera Therapeutics ($VERA) Stock Hub 2026: TRUTAKNA (Atacicept) Is FDA-Approved In IgAN — From Binary PDUFA To Launch And The Full-Approval Test https://www.merlintrader.com/vera-therapeutics-stock-hub/

Vera Therapeutics (VERA) stock hub: the FDA accelerated approval of TRUTAKNA (atacicept) in IgA nephropathy, the launch, the competition from Vertex, and the Q3 2026 confirmatory eGFR catalyst.

Merlintrader Trading Pub

Vera Therapeutics (Nasdaq: $VERA) Stock Hub: TRUTAKNA Approved In IgAN | Merlintrader Trading Pub

StockTwits Web

Vera Therapeutics Inc - Ordinary Shares - Class A

) Stock Hub 2026: TRUTAKNA (Atacicept) Is FDA-Approved In IgAN — From Binary PDUFA To Launch And The Full-Approval Test 